Maria Stella Pennisi

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

Elena Tirrò, Michele Massimino, Chiara Romano et al. · Frontiers in Oncology · 2019 · 31 citations · Full text

IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation

Michele Massimino, Maria Letizia Consoli, Maria Mesuraca et al. · Carcinogenesis · 2014 · 29 citations · Full text

Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells

Michele Massimino, Elena Tirrò, Stefania Stella et al. · Anticancer Research · 2018 · 23 citations · Full text

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib

Stefania Stella, Valentina Zammit, Silvia Rita Vitale et al. · International Journal of Molecular Sciences · 2019 · 21 citations · Full text

BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors

Maria Stella Pennisi, Stefania Stella, Silvia Rita Vitale et al. · Frontiers in Oncology · 2019 · 18 citations · Full text